The contractor shall acquire and store chemical compound libraries and conduct screening of interventional agents, using a high throughput format (i.e., greater than 96-wells per plate), with the…
Ended Awarded Last action
- Contract number
- 75N93018F00031
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $99,998
Award facts
- Contract value 100% obligated
- $99,998.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Southern Research Institute on July 26, 2018, with a ceiling value of $99,998.00 under a cost-plus-fixed-fee pricing structure. The order requires acquisition and storage of chemical compound libraries and high-throughput screening of interventional agents to identify and characterize at least one agent with activity to block HIV infection, inhibit HIV gene expression and replication, or cure infected cells of HIV infection.
Southern Research Institute, a non-profit research organization, will serve as an in vitro testing resource for HIV therapeutics and topical microbicides. Place of performance is Birmingham, Alabama. The order is scheduled for ultimate completion on July 31, 2019. No set-aside was used.
Description
The contractor shall acquire and store chemical compound libraries and conduct screening of interventional agents, using a high throughput format (i.e., greater than 96-wells per plate), with the objective of identifying and characterizing at least one (1) agent with activity to block HIV infection, inhibit HIV gene expression and replication, or cure infected cells of HIV infection.
Quick answers
Who was awarded contract 75N93018F00031?
75N93018F00031 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 26, 2018.
How much is contract 75N93018F00031 worth?
The government has obligated $99,998 on 75N93018F00031.
Is contract 75N93018F00031 an order under another contract?
Yes. 75N93018F00031 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93018F00031 competed?
The extent of competition for 75N93018F00031 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award